LPL Financial’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
45,557
+4,452
+11% +$42.5K ﹤0.01% 5149
2026
Q1
$375K Sell
41,105
-620
-1% -$5.2K ﹤0.01% 5022
2025
Q4
$310K Buy
41,725
+597
+1% +$4.29K ﹤0.01% 5122
2025
Q3
$275K Hold
41,128
﹤0.01% 5114
2025
Q2
$272K Hold
41,128
﹤0.01% 4843
2025
Q1
$376K Sell
41,128
-85
-0.2% -$849 ﹤0.01% 4413
2024
Q4
$433K Sell
41,213
-1,341
-3% -$15.9K ﹤0.01% 4219
2024
Q3
$509K Buy
42,554
+2,212
+5% +$19.1K ﹤0.01% 3985
2024
Q2
$232K Buy
40,342
+319
+0.8% +$1.75K ﹤0.01% 4456
2024
Q1
$208K Sell
40,023
-2,250
-5% -$11K ﹤0.01% 4480
2023
Q4
$223K Hold
42,273
﹤0.01% 4313
2023
Q3
$140K Buy
42,273
+2,250
+6% +$7.89K ﹤0.01% 4349
2023
Q2
$116K Hold
40,023
﹤0.01% 4300
2023
Q1
$42.8K Buy
40,023
+30,000
+299% +$57.4K ﹤0.01% 4325
2022
Q4
$26.2K Buy
+10,023
New +$43.8K ﹤0.01% 4340

Other funds holding BVS

LPL Financial's BVS Position: Q2 2026 in Review

LPL Financial increased its Bioventus (BVS) stake by 11% in Q2 2026, buying an estimated $42.5K and bringing the position to 45,557 shares worth $430K. The position accounts for ﹤0.01% of the portfolio, ranked #5149.

LPL Financial first reported a position in BVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $509K in Q3 2024. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • LPL Financial held 45,557 shares of Bioventus worth $430K as of Q2 2026.
  • LPL Financial bought 4,452 Bioventus shares in Q2 2026, an estimated $42.5K.
  • Bioventus made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5149 holding.
  • LPL Financial first reported a position in Bioventus in Q4 2022 and has held it in 15 quarters since.
  • LPL Financial's Bioventus position peaked at $509K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.